Graft-versus-host disease (GVHD)* is a frequent complication of allogeneic bone marrow
transplantation. The potentially beneficial effect of phototherapy for treatment of cutaneous …

Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …

Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic bone
marrow transplantation. Immunosuppressive treatment regimens carry the potential of …

The article by Besnier et al. in the July 15, 1997, issue ofTransplantation (1997; 64: 49) well
described the outcome of seven patients with graft-versus-host disease (GVHD)(two acute …

Background: Chronic cutaneous graft-versus-host disease (GvHD) can arise as a late
complication after allogeneic bone marrow transplantation. Patients with extensive disease …

For several years, psoralen and UV-A light (PUVA) therapy has been used in the treatment
of chronic graft-versus-host disease (GvHD) following allogeneic bone marrow …

Graft versus host disease (GVHD) is an important problem following allogenic bone marrow
transplantation (BMT). The beneficial effects of photochemotherapy with psoralens plus UVA …

Cutaneous involvement in graft versus host disease (GVHD) after allogeneic hematopoietic
cell transplant can be separated into acute GVHD (aGVHD), lichenoid chronic GVHD …

Background: Cutaneous chronic graft versus host disease (GVHD) is a severe complication
following allogeneic stem cell (PBSCT) and bone marrow transplantation (BMT) …

Graft‐versus‐host disease (GvHD) is a common and often serious complication of
hematopoietic stem cell transplantation. There are two major forms of GvHD: an acute form …